0 CHECKOUT

King Pharmaceuticals, Inc - SWOT, Strategy and Corporate Finance Report

  • ID: 2488880
  • January 2013
  • 42 pages
  • MarketLine

King Pharmaceuticals, Inc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on King Pharmaceuticals, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting King Pharmaceuticals, Inc in the form of a SWOT analysis
- An in-depth view of the business model of King Pharmaceuticals, Inc including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for King Pharmaceuticals, Inc
- Intelligence on King Pharmaceuticals, Incnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about King Pharmaceuticals, Inc, such as business expansion, restructuring, and READ MORE >

Note: Product cover images may vary from those shown

Company Snapshot
King Pharmaceuticals, Inc: Company Overview
King Pharmaceuticals, Inc: Overview and Key Facts

King Pharmaceuticals, Inc: Overview

King Pharmaceuticals, Inc: Key Facts
King Pharmaceuticals, Inc: Key Employees
King Pharmaceuticals, Inc: Key Employee Biographies
King Pharmaceuticals, Inc: Major Products and Services
King Pharmaceuticals, Inc: Company History
King Pharmaceuticals, Inc: Management Statement
King Pharmaceuticals, Inc: Key Competitors
King Pharmaceuticals, Inc: Company Analysis
King Pharmaceuticals, Inc: Business Description
King Pharmaceuticals, Inc: SWOT Analysis

King Pharmaceuticals, Inc: SWOT Overview

King Pharmaceuticals, Inc: Strengths

King Pharmaceuticals, Inc: Weaknesses

King Pharmaceuticals, Inc: Opportunities

King Pharmaceuticals, Inc: Threats
King Pharmaceuticals, Inc: Corporate Financial Deals Activity
King Pharmaceuticals, Inc: Financial Deals Overview
King Pharmaceuticals, Inc: Targets and Partners
King Pharmaceuticals, Inc: Top Deals 2009 - 2013YTD-
King Pharmaceuticals, Inc: Advisors

King Pharmaceuticals, Inc: Top Legal Advisors

King Pharmaceuticals, Inc: Top Financial Advisors
King Pharmaceuticals, Inc: Partnership
King Pharmaceuticals, Inc: Private Equity and Ownership
King Pharmaceuticals, Inc: Recent Developments
King Pharmaceuticals, Inc: News and Events Summary
King Pharmaceuticals, Inc: Business Expansion
King Pharmaceuticals, Inc: Corporate Governance
King Pharmaceuticals, Inc: Financial Deals
King Pharmaceuticals, Inc: Financial Performance
King Pharmaceuticals, Inc: Regulatory and Legal Events
King Pharmaceuticals, Inc: Research & Development
King Pharmaceuticals, Inc: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: King Pharmaceuticals, Inc: Key Facts
Table 2: King Pharmaceuticals, Inc: Key Employees
Table 3: King Pharmaceuticals, Inc: Key Competitors
Table 4: King Pharmaceuticals, Inc: Deal Activity by Deal Type - Volume (2009 - YTD-2013)
Table 5: King Pharmaceuticals, Inc: Targets and Partners
Table 6: King Pharmaceuticals, Inc: Top Deals 2009 - 2013YTD-
Table 7: King Pharmaceuticals, Inc: Legal Advisor Ranking by Value (US$m)
Table 8: King Pharmaceuticals, Inc: Financial Advisor Ranking by Value (US$m)
Table 9: King Pharmaceuticals, Inc: Partnership Volume and Value Trend (2009 - YTD-2013)
Table 10: King Pharmaceuticals, Inc: Partnership Trend by Deal Type (2009 - YTD-2013)
Table 11: King Pharmaceuticals, Inc: Private Equity and Ownership Volume and Value Trend (2009 - YTD-2013)
Table 12: King Pharmaceuticals, Inc: Private Equity and Ownership Volume by Deal Type (2009 - YTD-2013)
Table 13: King Pharmaceuticals, Inc: News and Events Summary
Table 14: King Pharmaceuticals, Inc: Business Expansion
Table 15: King Pharmaceuticals, Inc: Corporate Governance
Table 16: King Pharmaceuticals, Inc: Financial Deals
Table 17: King Pharmaceuticals, Inc: Financial Performance
Table 18: King Pharmaceuticals, Inc: Regulatory and Legal Events
Table 19: King Pharmaceuticals, Inc: Research & Development
Table 20: King Pharmaceuticals, Inc: Strategy and Operations

List of Figures

Figure 1: King Pharmaceuticals, Inc: Deal Activity by Deal Type - Volume (2009 - YTD-2013)
Figure 2: King Pharmaceuticals, Inc: Partnership Volume and Value Trend (2009 - YTD-2013)
Figure 3: King Pharmaceuticals, Inc: Partnership Trend by Deal Type (2009 - YTD-2013)
Figure 4: King Pharmaceuticals, Inc: Private Equity and Ownership Volume and Value Trend (2009 - YTD-2013)
Figure 5: King Pharmaceuticals, Inc: Private Equity and Ownership Volume by Deal Type (2009 - YTD-2013)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • UBS AG
  • RBC Capital Markets
  • Credit Suisse Group
  • J.P. Morgan & Co.
  • Deloitte LLP.